Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
The current price of Merck & Co Inc in the market is 5 096,54 ₴, with a 24-hour trading volume of 11,21B ₴. The asset's market cap is 12,58T ₴, after moving 2.02% in the last day.
Tokenized Merck & Co Inc is trading at 5 093,51 ₴, with a tokenized market cap of 37,1M ₴ and a 24-hour trading volume of 44,44M ₴. The tokenized asset has moved -2.60% in the past 24 hours.